SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,327,787,255 |
| Positions | 63 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| TANGO THERAPEUTICS INC | TNGX | COM | $339,990,606 | 10,876,219 |
| REVOLUTION MEDICINES INC | RVMD | COM | $93,640,000 | 500,000 |
| ABIVAX SA | ABVX | SPONSORED ADS | $80,622,300 | 605,000 |
| UNIQURE NV | QURE | SHS | $69,241,998 | 1,503,300 |
| KODIAK SCIENCES INC | KOD | COM | $57,567,296 | 1,477,600 |
| KYMERA THERAPEUTICS INC | KYMR | COM | $49,204,897 | 429,100 |
| DEFINIUM THERAPEUTICS INC | DFTX | COM SHS | $46,969,440 | 998,500 |
| REPLIMUNE GROUP INC | REPL | COM | $44,091,810 | 3,983,000 |
| CELCUITY INC | CELC | COM | $43,577,368 | 416,530 |
| Q32 BIO INC | QTTB | COM | $40,122,209 | 3,149,310 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.